Clin2
NCT06468436Possibly a fitNot yet recruiting

Calming medicines for ICU patients on a breathing machine

AgedIntensive Care UnitsVentilators, MechanicalDexmedetomidineEsketamineDelirium

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests a combination of two medicines (dexmedetomidine and esketamine) to help ICU patients who are on a breathing machine feel calm and have less pain. The goal is to find a safe and effective way to keep patients comfortable while they recover.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,508 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be an adult (18 years or older).
  • You must be in the intensive care unit (ICU) and need a breathing machine (ventilator) for at least 24 hours.
  • You must need medication to keep you calm and comfortable while on the ventilator.
  • You cannot be pregnant or breastfeeding.
  • You cannot have certain brain conditions (like schizophrenia, epilepsy, or Parkinson's disease) or serious heart rhythm problems.
  • You cannot be allergic to the study drugs (dexmedetomidine or esketamine).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07308756Recruiting· Phase 4
Study on two drugs for better recovery after surgery

This trial tests if giving two medicines, dexmedetomidine and esketamine, during and after surgery can help you feel better and recover more comfortably. It is for adults having general anesthesia for at least one hour who will use a patient-controlled pain pump afterward.

Beijing, Beijing Municipality
NCT07377981Not yet recruiting· Phase 4
Combination sedative for delirium in ICU patients on breathing support

This trial tests whether combining two sedative medications, esketamine and dexmedetomidine, is safer and more effective than using dexmedetomidine alone for treating hyperactive delirium in ICU patients who need breathing support. If you or a loved one are experiencing severe confusion and agitation while on a breathing machine, this study may offer a new treatment option.

Nanjing, Jiangsu
NCT06824077Not yet recruiting· Early Phase 1
Improving sleep in the intensive care unit with a relaxation medicine

This study tests whether giving a medicine called dexmedetomidine (which helps people relax and sleep) as part of a sleep-promoting routine can reduce confusion and delirium in the intensive care unit (ICU). It may help you sleep better and recover more smoothly.

NCT06993194Not yet recruiting
Comparing two medicines for calming ICU patients with brain injury

This study tests two medications, haloperidol and dexmedetomidine, to see which works better for reducing confusion and agitation in patients who are on a breathing machine after a traumatic brain injury. If you or a loved one is in the ICU with a brain injury and is restless or confused, this trial may help find better ways to manage those symptoms.

NCT07066605Recruiting
Dexmedetomidine for agitation during breathing tube removal

This trial tests whether a sedative called dexmedetomidine can reduce agitation in ICU patients when they are being weaned off a breathing tube. If you experience restlessness or agitation during the weaning process, this medication might help you stay calm.

Sohag
NCT06251375Not yet recruiting· Phase 4
Early sedation for older patients on breathing machines

This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.

Toronto, Ontario

Hear when a new Aged trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.